NCT07436858
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- The Netherlands Cancer Institute - Antoni van Leeuwenhoek Amsterdam, North Holland, Netherlands
Clinical trial condition
HER2 Expression
Explore clinical trials studying HER2 Expression. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
HER2 Expression trial results
Not yet recruiting
Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor
NCT07631884
- Conditions
- Advanced Malignant Solid Neoplasm, Biliary Tract Diseases, Biliary Tract Neoplasms, +56 more
- Locations
-
Not specified